Rating Rationale
December 31, 2020 | Mumbai
Resonance Specialties Limited
Ratings removed from 'Watch Developing'; Ratings reaffirmed
 
Rating Action
Total Bank Loan Facilities Rated Rs.12 Crore
Long Term Rating CRISIL BB+/Stable (Removed from 'Rating Watch with Developing Implications'; Rating Reaffirmed)
Short Term Rating CRISIL A4+ (Removed from 'Rating Watch with Developing Implications'; Rating Reaffirmed)
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
Detailed Rationale

CRISIL has removed its ratings on the bank facilities of Resonance Specialties Limted (RSL) from 'Rating Watch with Developing Implications' and has assigned its 'Stable' outlook to the long-term facilities. The ratings have been reaffirmed at 'CRISIL BB+/CRISIL A4+'.
 
CRISIL had on October 13, 2020, placed the rating on 'watch with developing implications'  following an announcement by RSL that Maker Laboratories Ltd and Kaygee Investments Private Ltd (acquirers) have signed a share purchase agreement to acquire majority stake of 54.24% in RSL. Acquirers had also made an open offer to acquire additional 26% from the public shareholders as required by the regulatory guidelines
 
The rating is removed from watch as the acquisition has now been completed and Makers Laboratories Ltd and Kaygee Investments Pvt Ltd have acquired 54.24% stake in RSL. The management, vide its announcement dated December 21, 2020, has confirmed the change in management. Clarity with respect to new shareholding pattern and management structure are also available. Benefits expected from association with the acquiring group and its impact on the company's business and financial risk profiles is a key monitorable.
 
The ratings continues to reflect the established presence of RSL in the specialty chemicals industry and comfortable capital structure. These strengths are partially offset by a modest scale of operations and large working capital requirement.

Key Rating Drivers & Detailed Description
Strengths:
* Established market position: Presence of over 25 years in the speciality chemicals manufacturing business has enabled the company to establish strong relationships with customers and suppliers. Revenue rose by 34.93% to Rs 57.52 crore in fiscal 2020 from Rs 42.63 crore in fiscal 2019, aided by higher exports. Impact of disruptions caused by outbreak of Covid-19 pandemic is likely to be marginal and revenue is expected to grow by 15-17% and profitability is likely to marginally decline
 
* Above-average financial risk profile: Networth was moderate and total outside liabilities to adjusted networth ratio strong at Rs 24.61 crore and 0.42 time, respectively, as on March 31 2020 (Rs 20.51 crore and 0.57 time, respectively, as on March 31, 2019). Interest coverage ratio improved to 27.24 times in fiscal 2020 from 11.6 times in the previous fiscal. Return on capital employed also increased to 35.9% from 24.1%.
 
Weaknesses:
* Working capital-intensive operations: Gross current assets (GCAs) were moderately high at 146 days as on March 31, 2020. However, receivables realisation helped to improve GCAs from 180 days in the previous fiscal. Working capital requirement is expected to remain large over the medium term, with GCAs of 180-190 days.
 
* Susceptibility to prices of raw material imports: RSL imports nearly half of its raw material requirement. Input prices are volatile and the company has only moderate ability to pass on fluctuations in input rates. Hence, RSL will remain exposed to any adverse movement in raw material prices.
Liquidity Adequate

Net cash accrual was Rs 5.03 crore for fiscal 2020 and should be Rs 7-8 crore over the medium term against nil debt obligation. Fund-based limit of Rs 3.4 crore was utilised marginally at 1.59% on average during the 12 months through August 31, 2020. Current ratio was adequate at 2.83 times as on March 31, 2020. The company also had adequate cash balance of Rs 1.92 crore.

Outlook: Stable

CRISIL believes RSL will continue to benefit from the extensive experience of its promoters and focus on exports. Financial risk profile is expected to remain moderate over the medium term.

Rating sensitivity factors
Upward factors
* Sustained revenue growth and higher operating margin strengthening net cash accrual to over Rs 7 crore on a sustained basis.
* Better working capital cycle and liquidity further improving financial risk profile
 
Downward factors
* Decline in revenue and operating margin  constraining net cash accrual below Rs 3.5 crore
* Further stretch in working capital cycle or substantial debt-funded capex or dividend pay-out affecting financial risk profile

About the Company

RSL was set up in 1989 by first-generation entrepreneur, Dr AB Gupta. The company manufactures and trades in specialty chemicals such as lutidine and picoline, and their derivatives. These chemicals are used in diverse industries, including pharmaceuticals, agro chemicals, dyes and paints, food, and animal feeds. Manufacturing unit is in Tarapur, Maharashtra.
 
Makers Laboratories Ltd and Kaygee Investments Pvt Ltd have now acquired 54.24% stake in RSL. The management, vide its announcement dated December 21, 2020, has confirmed the change in management.

Key Financial Indicators
As on / for the period ended March 31  Units 2020 2019
Operating income Rs crore 57.52 42.63
Reported profit after tax (PAT) Rs crore 5.51 3.2
PAT margin % 9.6 7.52
Adjusted debt/adjusted networth Times 0.00 0.00
Interest coverage Times 26.94 11.58

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments and are included (where applicable) in the Annexure -- Details of Instrument in this Rating Rationale. For more details on the CRISIL complexity levels, please visit www.crisil.com/complexity-levels.
Annexure - Details of Instrument(s)
ISIN Name of instrument Date of
Allotment
Coupon
Rate (%)
Maturity date Complexity  Level Issue Size
(Rs.Cr)
Rating Assigned
with Outlook
NA Bank Guarantee NA NA NA NA 1 CRISIL A4+
NA Cash Credit NA NA NA NA 3.4 CRISIL BB+/Stable
NA Inland/Import Letter of Credit NA NA NA NA 3 CRISIL A4+
NA Proposed Long Term Bank Loan Facility NA NA NA NA 4.6 CRISIL BB+/Stable
Annexure - Rating History for last 3 Years
  Current 2020 (History) 2019  2018  2017  Start of 2017
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund-based Bank Facilities  LT/ST  8.00  CRISIL BB+/Stable  13-10-20  CRISIL BB+/Watch Developing  23-10-19  CRISIL BB/Stable      30-11-17  CRISIL BB-/Stable  CRISIL BB/Stable 
            24-01-19  CRISIL BB-/Stable           
Non Fund-based Bank Facilities  LT/ST  4.00  CRISIL A4+  13-10-20  CRISIL A4+/Watch Developing  23-10-19  CRISIL A4+      30-11-17  CRISIL A4+  CRISIL A4+ 
            24-01-19  CRISIL A4+           
All amounts are in Rs.Cr.
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Bank Guarantee 1 CRISIL A4+ Bank Guarantee 1 CRISIL A4+/Watch Developing
Cash Credit 3.4 CRISIL BB+/Stable Cash Credit 3.4 CRISIL BB+/Watch Developing
Inland/Import Letter of Credit 3 CRISIL A4+ Inland/Import Letter of Credit 3 CRISIL A4+/Watch Developing
Proposed Long Term Bank Loan Facility 4.6 CRISIL BB+/Stable Proposed Long Term Bank Loan Facility 4.6 CRISIL BB+/Watch Developing
Total 12 -- Total 12 --
Links to related criteria
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating criteria for manufaturing and service sector companies
Rating Criteria for Chemical Industry
CRISILs Bank Loan Ratings
Understanding CRISILs Ratings and Rating Scales

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Rahul Guha
Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8320
rahul.guha@crisil.com


Jumana Badshah
Associate Director - CRISIL Ratings
CRISIL Limited
D:+91 22 3342 8324
Jumana.Badshah@crisil.com


Aashpreet Kaur Giddey
Rating Analyst - CRISIL Ratings
CRISIL Limited
B:+91 22 3342 3000
Aashpreet.Giddey@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL